Global Hepatitis C Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4809324
- 86 Pages
- February 2022
- Pharmaceuticals
The United States Hepatitis C Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatitis C Drugs market, reaching US$ million by the year 2028. As for the Europe Hepatitis C Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hepatitis C Drugs players cover Gilead sciences, Abbvi, Johnson & Johnson, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis C Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Anti-Viral
Immuno-modulators
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Gilead sciences
Abbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis C Drugs Market Size 2017-2028
2.1.2 Hepatitis C Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hepatitis C Drugs Segment by Type
2.2.1 Anti-Viral
2.2.2 Immuno-modulators
2.2.3 Others
2.3 Hepatitis C Drugs Market Size by Type
2.3.1 Hepatitis C Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
2.4 Hepatitis C Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Hepatitis C Drugs Market Size by Application
2.5.1 Hepatitis C Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
3 Hepatitis C Drugs Market Size by Player
3.1 Hepatitis C Drugs Market Size Market Share by Players
3.1.1 Global Hepatitis C Drugs Revenue by Players (2020-2022)
3.1.2 Global Hepatitis C Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Hepatitis C Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hepatitis C Drugs by Regions
4.1 Hepatitis C Drugs Market Size by Regions (2017-2022)
4.2 Americas Hepatitis C Drugs Market Size Growth (2017-2022)
4.3 APAC Hepatitis C Drugs Market Size Growth (2017-2022)
4.4 Europe Hepatitis C Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Hepatitis C Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Hepatitis C Drugs Market Size by Country (2017-2022)
5.2 Americas Hepatitis C Drugs Market Size by Type (2017-2022)
5.3 Americas Hepatitis C Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis C Drugs Market Size by Region (2017-2022)
6.2 APAC Hepatitis C Drugs Market Size by Type (2017-2022)
6.3 APAC Hepatitis C Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hepatitis C Drugs by Country (2017-2022)
7.2 Europe Hepatitis C Drugs Market Size by Type (2017-2022)
7.3 Europe Hepatitis C Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis C Drugs by Region (2017-2022)
8.2 Middle East & Africa Hepatitis C Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Hepatitis C Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hepatitis C Drugs Market Forecast
10.1 Global Hepatitis C Drugs Forecast by Regions (2023-2028)
10.1.1 Global Hepatitis C Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Hepatitis C Drugs Forecast
10.1.3 APAC Hepatitis C Drugs Forecast
10.1.4 Europe Hepatitis C Drugs Forecast
10.1.5 Middle East & Africa Hepatitis C Drugs Forecast
10.2 Americas Hepatitis C Drugs Forecast by Country (2023-2028)
10.2.1 United States Hepatitis C Drugs Market Forecast
10.2.2 Canada Hepatitis C Drugs Market Forecast
10.2.3 Mexico Hepatitis C Drugs Market Forecast
10.2.4 Brazil Hepatitis C Drugs Market Forecast
10.3 APAC Hepatitis C Drugs Forecast by Region (2023-2028)
10.3.1 China Hepatitis C Drugs Market Forecast
10.3.2 Japan Hepatitis C Drugs Market Forecast
10.3.3 Korea Hepatitis C Drugs Market Forecast
10.3.4 Southeast Asia Hepatitis C Drugs Market Forecast
10.3.5 India Hepatitis C Drugs Market Forecast
10.3.6 Australia Hepatitis C Drugs Market Forecast
10.4 Europe Hepatitis C Drugs Forecast by Country (2023-2028)
10.4.1 Germany Hepatitis C Drugs Market Forecast
10.4.2 France Hepatitis C Drugs Market Forecast
10.4.3 UK Hepatitis C Drugs Market Forecast
10.4.4 Italy Hepatitis C Drugs Market Forecast
10.4.5 Russia Hepatitis C Drugs Market Forecast
10.5 Middle East & Africa Hepatitis C Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Hepatitis C Drugs Market Forecast
10.5.2 South Africa Hepatitis C Drugs Market Forecast
10.5.3 Israel Hepatitis C Drugs Market Forecast
10.5.4 Turkey Hepatitis C Drugs Market Forecast
10.5.5 GCC Countries Hepatitis C Drugs Market Forecast
10.6 Global Hepatitis C Drugs Forecast by Type (2023-2028)
10.7 Global Hepatitis C Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Gilead sciences
11.1.1 Gilead sciences Company Information
11.1.2 Gilead sciences Hepatitis C Drugs Product Offered
11.1.3 Gilead sciences Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Gilead sciences Main Business Overview
11.1.5 Gilead sciences Latest Developments
11.2 Abbvi
11.2.1 Abbvi Company Information
11.2.2 Abbvi Hepatitis C Drugs Product Offered
11.2.3 Abbvi Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbvi Main Business Overview
11.2.5 Abbvi Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Hepatitis C Drugs Product Offered
11.3.3 Johnson & Johnson Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Hepatitis C Drugs Product Offered
11.4.3 Merck Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Information
11.5.2 Glaxosmithkline Hepatitis C Drugs Product Offered
11.5.3 Glaxosmithkline Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Glaxosmithkline Main Business Overview
11.5.5 Glaxosmithkline Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Hepatitis C Drugs Product Offered
11.6.3 Novartis Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Hepatitis C Drugs Product Offered
11.7.3 Bristol-Myers Squibb Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Hepatitis C Drugs Product Offered
11.8.3 Roche Hepatitis C Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
12 Research Findings and Conclusion
Table 1. Hepatitis C Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Anti-Viral
Table 3. Major Players of Immuno-modulators
Table 4. Major Players of Others
Table 5. Hepatitis C Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Hepatitis C Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
Table 8. Hepatitis C Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Hepatitis C Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
Table 11. Global Hepatitis C Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Hepatitis C Drugs Revenue Market Share by Player (2020-2022)
Table 13. Hepatitis C Drugs Key Players Head office and Products Offered
Table 14. Hepatitis C Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hepatitis C Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Hepatitis C Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Hepatitis C Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Hepatitis C Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Hepatitis C Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Hepatitis C Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
Table 25. APAC Hepatitis C Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Hepatitis C Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Hepatitis C Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Hepatitis C Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
Table 31. Europe Hepatitis C Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Hepatitis C Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Hepatitis C Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Hepatitis C Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Hepatitis C Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Hepatitis C Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Hepatitis C Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Hepatitis C Drugs
Table 44. Key Market Challenges & Risks of Hepatitis C Drugs
Table 45. Key Industry Trends of Hepatitis C Drugs
Table 46. Global Hepatitis C Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Hepatitis C Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Hepatitis C Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Hepatitis C Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Hepatitis C Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Hepatitis C Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 52. Gilead sciences Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 53. Gilead sciences Hepatitis C Drugs Product Offered
Table 54. Gilead sciences Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Gilead sciences Main Business
Table 56. Gilead sciences Latest Developments
Table 57. Abbvi Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 58. Abbvi Hepatitis C Drugs Product Offered
Table 59. Abbvi Main Business
Table 60. Abbvi Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Abbvi Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 63. Johnson & Johnson Hepatitis C Drugs Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Johnson & Johnson Latest Developments
Table 67. Merck Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 68. Merck Hepatitis C Drugs Product Offered
Table 69. Merck Main Business
Table 70. Merck Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Merck Latest Developments
Table 72. Glaxosmithkline Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 73. Glaxosmithkline Hepatitis C Drugs Product Offered
Table 74. Glaxosmithkline Main Business
Table 75. Glaxosmithkline Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Glaxosmithkline Latest Developments
Table 77. Novartis Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 78. Novartis Hepatitis C Drugs Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Novartis Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Hepatitis C Drugs Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Roche Details, Company Type, Hepatitis C Drugs Area Served and Its Competitors
Table 88. Roche Hepatitis C Drugs Product Offered
Table 89. Roche Main Business
Table 90. Roche Hepatitis C Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Roche Latest Developments
List of Figures
Figure 1. Hepatitis C Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hepatitis C Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hepatitis C Drugs Market Size Market Share by Type in 2021
Figure 7. Hepatitis C Drugs in Hospitals
Figure 8. Global Hepatitis C Drugs Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Hepatitis C Drugs in Clinics
Figure 10. Global Hepatitis C Drugs Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Global Hepatitis C Drugs Market Size Market Share by Application in 2021
Figure 12. Global Hepatitis C Drugs Revenue Market Share by Player in 2021
Figure 13. Global Hepatitis C Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Hepatitis C Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Hepatitis C Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Hepatitis C Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Hepatitis C Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Hepatitis C Drugs Value Market Share by Country in 2021
Figure 19. Americas Hepatitis C Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Hepatitis C Drugs Market Size Market Share by Application in 2021
Figure 21. United States Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Hepatitis C Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Hepatitis C Drugs Market Size Market Share by Application in 2021
Figure 27. China Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Hepatitis C Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Hepatitis C Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Hepatitis C Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Hepatitis C Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Hepatitis C Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Hepatitis C Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
